bpc-157 randomized clinical trial humans BPC-157: What the Science Actually Says BPC-157 Peptides in Orthopedics: What

Most users tolerate it well

The researchers own conclusion was that it was well absorbed. Why that number is the whole ballgame: ~38% of an oral dose reaching circulation is a genuinely good absorption fraction for an oral compound plenty of approved oral products sit at or below that

It was designed to isolate the fat-metabolising activity localised to the C-terminal region of human growth hormone, while removing the receptor binding responsible for GHs growth-promoting and insulin-antagonistic effects

doi: 10.4088/PCC.11m01326

The primary assumptions were that BPC-157 is highly stable, biocompatible, and sufficient to exert action when presented by itself